Novo Nordisk's Rybelsus has become the first oral GLP-1 agonist to pick up a regulatory approval for cardiovascular risk ...

Onsite in Princeton, New Jersey for the Axtria Ignite 2025 conference, web editor Nicole Raleigh spoke with Ritesh Mehra, CFO ...

Last October, Novartis paid $150 million upfront to Monte Rosa – with up to $2.1 billion at the back end – for an ...

Swedish biotech Camurus is reportedly in talks to acquire its US partner Braeburn Pharma in a deal that would give it full ...

An accompanying study of the high dose in adults with a BMI of 30 or more and type 2 diabetes, STEP UP T2D, has also been ...

AbbVie has lost a legal challenge seeking to block a Mississippi law that requires it to provide discounted medicines to some ...

To address these challenges, there is a growing focus on rethinking chronic wound management, with particular emphasis on ...